Becker, A.E. and Kleinman, A. (2013). Mental health and the global agenda. New England Journal of Medicine, 369, 1380–1.
Cooper, J.E., Kendell, R.E., Gurland, B.J., et al. (1969). Cross-national study of diagnosis of the mental disorders: some results from the first comparative investigation. American Journal of Psychiatry, 10 Suppl, 21–9.
Cuthbert, B. and Insel, T. (2010). The data of diagnosis: new approaches to psychiatric classification. Psychiatry, 73, 311–4.
Dohrenwend, B.P. and Dohrenwend, B.S. (1982). Perspectives on the past and future of psychiatric epidemiology. The 1981 Rema Lapouse Lecture. American Journal of Public Health, 72, 1271–9.
Frances, A.J., Widiger, T.A., and Pincus, H.A. (1989). The development of DSM-IV. Archives of General Psychiatry, 46, 373–5.
GBD Collaborators, Murray, C.J., Barber, R.M., et al. (2015). Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet, 386, 2145–91.
Goodwin, R.D. and Gorman, J.M. (2002). Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. American Journal of Psychiatry, 159, 1935–7.
Hasin, D.S. and Grant, B.F. (2015). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Social Psychiatry and Psychiatric Epidemiology, 50, 1609–40.
Hyman, S.E. (2010). The diagnosis of mental disorders: the problem of reification. Annual Review of Clinical Psychology, 6, 155–79.
Insel, T., Cuthbert, B., Garvey, M., et al. (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry, 167, 748–51.
Karam, E.G., Andrews, G., Bromet, E., et al. (2010). The role of criterion A2 in the DSM-IV diagnosis of posttraumatic stress disorder. Biological Psychiatry, 68, 465–73.
Kendler, K.S. (2009). An historical framework for psychiatric nosology. Psychological Medicine, 39, 1935–41.
Kendler, K.S. (2016). The phenomenology of major depression and the representativeness and nature of DSM criteria. American Journal of Psychiatry, 173, 771–80.
Kendler, K.S. and First, M.B. (2010). Alternative futures for the DSM revision process: iteration v. paradigm shift. British Journal of Psychiatry, 197, 263–5.
Kendler, K.S., Munoz, R.A., and Murphy, G. (2010). The development of the Feighner criteria: a historical perspective. American Journal of Psychiatry, 167, 134–42.
Kessler, R.C. (2000a). The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatrica Scandinavica Supplementum, 7–13.
Kessler, R.C. (2000b). Psychiatric epidemiology: selected recent advances and future directions. Bulletin of the World Health Organization, 78, 464–74.
Kessler, R.C., Andrade, L.H., Bijl, R.V., et al. (2002). The effects of co-morbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. International Consortium in Psychiatric Epidemiology. Psychological Medicine, 32, 1213–25.
Kessler, R.C., Ruscio, A.M., Shear, K., et al. (2010). Epidemiology of anxiety disorders. Current Topics in Behavioral Neurosciences, 2, 21–35.
Kessler, R.C. and Üstün, T.B. (2004). The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13, 93–121.
Kupfer, D.J. and Regier, D.A. (2011). Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. American Journal of Psychiatry, 168, 672–4.
Lee, S., Tsang, A., Ruscio, A.M., et al. (2009). Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries. Psychological Medicine, 39, 1163–76.
Maj, M. (2005). “Psychiatric comorbidity”: an artefact of current diagnostic systems? British Journal of Psychiatry, 186, 182–4.
McLaughlin, K.A., Koenen, K.C., Friedman, M.J., et al. (2015). Subthreshold posttraumatic stress disorder in the World Health Organization World Mental Health Surveys. Biological Psychiatry, 77, 375–84.
Moynihan, R., Heath, I., and Henry, D. (2002). Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal, 324, 886–91.
Patel, V. (2012). Global mental health: from science to action. Harvard Review of Psychiatry, 20, 6–12.
Prince, M., Patel, V., Saxena, S., et al. (2007). No health without mental health. Lancet, 370, 859–77.
Reed, G.M. and Ayuso-Mateos, J.L. (2011). Towards a more clinically useful International World Health Organisation classification of mental disorders. Revista Psiquiatria Salud Mental, 4, 113–6.
Regier, D.A., Kuhl, E.A., and Kupfer, D.J. (2013). The DSM-5: classification and criteria changes. Official Journal of the World Psychiatric Association, 12, 92–8.
Robins, L.N., Helzer, J.E., Weissman, M.M., et al. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949–58.
Rosenhan, D.L. (1973). On being sane in insane places. Science, 179, 250–8.
Ruscio, A.M., Chiu, W.T., Roy-Byrne, P., et al. (2007). Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. Journal of Anxiety Disorders, 21, 662–76.
Schlenger, W.E., Kulka, R.A., Fairbank, J.A., et al. (2007). The psychological risks of Vietnam: the NVVRS perspective. Journal of Traumatic Stress, 20, 467–79.
Spitzer, R.L., Williams, J.B., and Skodol, A.E. (1980). DSM-III: the major achievements and an overview. American Journal of Psychiatry, 137, 151–64.
Stein, D.J. (2014). An integrative approach to psychiatric diagnosis and research. World Psychiatry, 13, 51–3.
Stein, D.J. (2015). Disorder versus deviance: where to draw the boundary? Philosophy, Psychiatry and Psychology, 21, 262–5.
Stein, D.J., Koenen, K.C., Friedman, M.J., et al. (2013). Dissociation in Posttraumatic Stress Disorder: evidence from the World Mental Health Surveys. Biological Psychiatry, 73, 302–12.
Stein, D.J. and Nesse, R.M. (2011). Threat detection, precautionary responses, and anxiety disorders. Neuroscience and Biobehavioral Reviews, 35, 1075–9.
Stein, D.J. and Phillips, K.A. (2013). Patient advocacy and DSM-5. BMC Medicine, 11, 133.
Stein, D.J., Ruscio, A.M., Lee, S., et al. (2010). Subtyping social anxiety disorder in developed and developing countries. Depression and Anxiety, 27, 390–403.
Stein, D.J., Wessels, C., Zungu-Dirwayi, N., et al. (2001). Value and effectiveness of consumer advocacy groups: a survey of the anxiety disorders support group in South Africa. Depression and Anxiety, 13, 105–7.
Summerfield, D. (2012). Afterword: against “global mental health”. Transcultural Psychiatry, 49, 519–30.
Weich, S. and Araya, R. (2004). International and regional variation in the prevalence of common mental disorders: do we need more surveys? British Journal of Psychiatry, 184, 289–90.
Weissman, M.M., Bland, R.C., Canino, G.J., et al. (1994). The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. Journal of Clinical Psychiatry, 55 Suppl, 5–10.
Weissman, M.M., Bland, R.C., Canino, G.J., (1996). The cross-national epidemiology of social phobia: a preliminary report. International Clinical Psychopharmacology, 11 Suppl 3, 9–14.
Weissman, M.M., Myers, J.K., and Harding, P.S. (1978). Psychiatric disorders in a U.S. urban community: 1975–1976. American Journal of Psychiatry, 135, 459–62.
WHO International Consortium in Psychiatric Epidemiology (2000). Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bulletin of the World Health Organization, 78, 413–26.